|
A phase 2 trial of CRS-207 and pembrolizumab in adults with recurrence of metastatic gastric, gastroesophageal junction (GEJ), or esophageal adenocarcinomas. |
|
|
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Cardinal Health; Clovis Oncology; EMD Serono; Gritstone Bio; Lilly; Novartis; OncoMed |
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst) |
|
|
Honoraria - Celgene; Genentech/Roche; Merrimack |
Consulting or Advisory Role - Aduro Biotech; Bristol-Myers Squibb |
Research Funding - Celgene; Lilly |
Travel, Accommodations, Expenses - Lilly |
|
|
Honoraria - Amgen; Bristol-Myers Squibb; Five Prime Therapeutics; Foundation Medicine; Genentech/Roche; Genmab; Gritstone Bio; Guardant Health; Lilly; Merck; NantWorks; OncoPlex Diagnostics; Taiho Pharmaceutical |
Consulting or Advisory Role - Amgen; Genentech/Roche; OncoPlex Diagnostics |
Speakers' Bureau - Foundation Medicine; Genentech/Roche; Guardant Health; Lilly; NantWorks |
Research Funding - Genentech; OncoPlex Diagnostics |
|
|
Consulting or Advisory Role - Amgen; Array BioPharma; Five Prime Therapeutics; Novartis; Sirtex Medical |
Speakers' Bureau - Genentech |
Research Funding - Biomarin (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Plexxikon (Inst) |
Travel, Accommodations, Expenses - Amgen; Genentech |
|
|
Consulting or Advisory Role - Bayer |
Speakers' Bureau - Bristol-Myers Squibb |
Research Funding - Aduro Biotech (Inst); Array BioPharma (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); Sillajen (Inst) |
|
|
Employment - Aduro Biotech |
Stock and Other Ownership Interests - Aduro Biotech; Bavarian Nordic |
|
|
No Relationships to Disclose |
|
|
Employment - Aduro Biotech |
Stock and Other Ownership Interests - Aduro Biotech |
|
|
Employment - Aduro Biotech |
Stock and Other Ownership Interests - Aduro Biotech |
|
|
Employment - Aduro Biotech |
Leadership - Aduro Biotech |
Stock and Other Ownership Interests - Aduro Biotech |
Patents, Royalties, Other Intellectual Property - Aduro Biotech |
Travel, Accommodations, Expenses - Aduro Biotech |
|
|
Employment - Aduro Biotech |
Stock and Other Ownership Interests - Aduro Biotech; Bristol-Myers Squibb; Express Scripts; Johnson & Johnson; Merck; Zimmer Biomet |
|
|
No Relationships to Disclose |
|
|
Employment - Aduro Biotech |
Stock and Other Ownership Interests - Aduro Biotech |
Patents, Royalties, Other Intellectual Property - University of Southern California |
Other Relationship - Aduro Biotech |
|
|
Consulting or Advisory Role - AstraZeneca/MedImmune; Bayer |
Research Funding - Arog (Inst); Bristol-Myers Squibb (Inst); MedImmune (Inst); Merck (Inst) |
Travel, Accommodations, Expenses - AstraZeneca/MedImmune |